Cleared Traditional

K781077 - CONTROL, HEMATOLOGY, CH-60

K781077 is an FDA 510(k) clearance for CONTROL, manufactured by Dade, Baxter Travenol Diagnostics, Inc.. The device is a Class 2 Hematology device with product code JPK cleared through the Traditional 510(k) pathway after a 29-day FDA review.

K781077 · Dade, Baxter Travenol Diagnostics, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1978
Decision
29d
Days
Class 2
Risk

K781077 is an FDA 510(k) clearance for the CONTROL, HEMATOLOGY, CH-60. Classified as Mixture, Hematology Quality Control (product code JPK), Class II - Special Controls.

Submitted by Dade, Baxter Travenol Diagnostics, Inc. (Mchenry, US). The FDA issued a Cleared decision on July 27, 1978 after a review of 29 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.8625 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Dade, Baxter Travenol Diagnostics, Inc. devices

FDA 510(k) Submission Details - K781077

510(k) Number K781077 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 28, 1978
Decision Date July 27, 1978
Days to Decision 29 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
84d faster than avg
Panel avg: 113d · This submission: 29d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JPK Device Classification - Class 2, Special Controls

Product Code JPK Mixture, Hematology Quality Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.8625
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - JPK Mixture, Hematology Quality Control

All 166
Devices cleared under the same product code (JPK) and FDA review panel - the closest regulatory comparables to K781077.
ABNORMAL HEMATOLOGY CONTROL UNASSAYED
K781573 · Ortho Diagnostics, Inc. · Oct 1978
QUANTICEL-HRP
K781247 · Bhp Diagnostix, Inc. · Sep 1978
PLATELET CONTROL
K780980 · Bhp Diagnostix, Inc. · Jul 1978
PLATELET CONTROL
K780714 · Bhp Diagnostix, Inc. · Jun 1978
CELL-CHEX
K780140 · Streck Laboratories, Inc. · Mar 1978
HEMATOLOGY REFERENCE CONTROLS
K772195 · R&D Systems, Inc. · Feb 1978